Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17.4B |
| 2 |
Amazon
AMZN
|
+$2.49B |
| 3 |
NVIDIA
NVDA
|
+$2.18B |
| 4 |
Microsoft
MSFT
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.21B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$1.75B |
| 2 |
Broadcom
AVGO
|
+$1.56B |
| 3 |
Dell
DELL
|
+$1.09B |
| 4 |
SNDK
Sandisk
SNDK
|
+$899M |
| 5 |
T-Mobile US
TMUS
|
+$827M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.39% |
| 2 | Technology | 3.64% |
| 3 | Industrials | 1.09% |
| 4 | Consumer Discretionary | 0.89% |
| 5 | Financials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
CALL
Caleres
CAL
$425M
| $3.04M | ﹤0.01% |
+246,000
| New | +$3.19M |
|
4477
CALL
Iovance Biotherapeutics
IOVA
$4.24B
| $3.04M | ﹤0.01% |
730,100
+451,000
| +162% | +$1.71M |
|
4478
Regenxbio
RGNX
$524M
| $3.04M | ﹤0.01% |
253,493
+147,945
| +140% | +$1.23M |
|
4479
CALL
LGI Homes
LGIH
$1.18B
| $3.03M | ﹤0.01% |
47,600
+12,300
| +35% | +$588K |
|
4480
CALL
CPS Technologies
CPSH
$75.6M
| $3.03M | ﹤0.01% |
+548,700
| New | +$3.22M |
|
4481
CALL
Structure Therapeutics
GPCR
$2.78B
| $3.03M | ﹤0.01% |
56,400
-7,200
| -11% | -$319K |
|
4482
PUT
Defiance Quantum ETF
QTUM
$5.35B
| $3.03M | ﹤0.01% |
18,300
+3,100
| +20% | +$446K |
|
4483
PUT
Northern Trust
NTRS
$32.7B
| $3.02M | ﹤0.01% |
17,400
+11,500
| +195% | +$1.89M |
|
4484
FLEX LNG
FLNG
$1.75B
| $3.02M | ﹤0.01% |
107,786
+52,660
| +96% | +$1.63M |
|
4485
PUT
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$116M
| $3.02M | ﹤0.01% |
34,000
+2,500
| +8% | +$263K |
|
|
VMRK
4486
PUT
Vivmark Residential
VMRK
$50.8B
| $3.02M | ﹤0.01% |
44,500
-4,800
| -10% | -$311K |
|
4487
Avantis Emerging Markets Small Cap Equity ETF
AVEE
$135M
| $3.02M | ﹤0.01% |
43,555
-6,445
| -13% | -$449K |
|
4488
PUT
IDEAYA Biosciences
IDYA
$3.63B
| $3.02M | ﹤0.01% |
81,000
-67,600
| -45% | -$2.07M |
|
|
AXON
4489
Axon Enterprise
AXON
$35.9B
| $3.02M | ﹤0.01% |
5,382
+273
| +5% | +$114K |
|
|
THOR
4490
Thornburg Premium Income Builder ETF
THOR
$14.4M
| $3.02M | ﹤0.01% |
+120,838
| New | +$3.02M |
|
4491
Intapp
INTA
$2.87B
| $3.01M | ﹤0.01% |
119,587
-115,019
| -49% | -$2.62M |
|
4492
CALL
Thor Industries
THO
$3.71B
| $3.01M | ﹤0.01% |
40,100
+28,600
| +249% | +$2.2M |
|
4493
Citi Trends
CTRN
$476M
| $3.01M | ﹤0.01% |
+52,034
| New | +$2.49M |
|
4494
CALL
Rhythm Pharmaceuticals
RYTM
$6.66B
| $3.01M | ﹤0.01% |
27,100
-19,400
| -42% | -$1.75M |
|
4495
CALL
ProShares UltraShort Bitcoin ETF
SBIT
$155M
| $3.01M | ﹤0.01% |
43,200
+5,200
| +14% | +$261K |
|
4496
VanEck Uranium + Nuclear Energy ETF
NLR
$3.78B
| $3.01M | ﹤0.01% |
25,933
+16,800
| +184% | +$2.24M |
|
4497
Bausch + Lomb
BLCO
$6.15B
| $3.01M | ﹤0.01% |
181,520
-140,738
| -44% | -$2.24M |
|
4498
PUT
Tidewater
TDW
$4.57B
| $3.01M | ﹤0.01% |
45,100
-11,700
| -21% | -$928K |
|
4499
CALL
Everest Group
EG
$14.6B
| $3M | ﹤0.01% |
8,400
| – | – |
|
4500
Royalty Pharma
RPRX
$26B
| $3M | ﹤0.01% |
53,460
-2,346,922
| -98% | -$122M |
|
Similar funds
Jane Street's Q2 2026 Portfolio in Review
As of Q2 2026, Jane Street held 13,869 positions worth $1.21T, up 55% from $777B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jane Street deployed $44.4B of net new capital in Q2 2026, opening 2,565 new positions and adding to 4,995 existing holdings. Its largest new stake was Super Micro Computer Depositary Shares 7% Series A Preferred Stock: 10,590,097 shares worth $550M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Marvell Technology, an estimated $1.75B trimmed.
- Jane Street's largest Q2 2026 buy was Super Micro Computer Depositary Shares 7% Series A Preferred Stock: 10,590,097 shares worth $550M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $17.4B increase.
- Jane Street's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.75B.
- Jane Street fully exited iShares Core US Aggregate Bond ETF in Q2 2026, selling an estimated $239M.
- Jane Street's ten largest holdings make up 32% of its $1.21T portfolio in Q2 2026.
- Jane Street opened 2,565 new positions and closed 2,484 in Q2 2026.
- Jane Street's portfolio value rose 55% quarter-over-quarter to $1.21T.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.